Myelodysplastic Syndromes: Diagnosis, Classification, and Risk Stratification

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Release Date: April 27, 2017
Expiration Date: April 27, 2018

Expected time to complete this activity as designed: 45 minutes

There are no fees for participating in or receiving credit for this online activity.

Program Overview

Accurate diagnosis is critical in myelodysplastic syndromes (MDS), and new criteria and guidelines are refining how MDS is diagnosed and assessed. This focused activity will include practice recommendations for using the revised diagnostic criteria and for improving the accuracy of assessments in patients who present with cytopenias and may have MDS.

Target Audience

This activity is designed for physicians, pharmacists, physician assistants, and other health care professionals who have an interest in enhancing their clinical skills in myelodysplastic syndromes.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Identify the different classifications of MDS based on the revised WHO criteria
  • Recognize the risk of patients presenting with different types of MDS

Agenda

Myelodysplastic Syndromes: Diagnosis, Classification, and Risk Stratification – Rami S. Komrokji, MD

Instructions for Participation and Credit

This activity is eligible for credit through April 27, 2018. After this date, this activity will expire and no further credit will be awarded.

  1. Read the target audience, learning objectives, and faculty disclosures.
  2. You may be asked to complete a short pre-test before accessing the educational content. This must be completed in order to move forward in the activity.
  3. Complete the educational content as designed.
  4. Complete the post-test. To receive a certificate, you must receive a passing score of 70%.
  5. Complete the activity evaluation survey to provide feedback and information useful for future programming.
  6. Certificates for CME may be printed immediately after successfully completing the post-test and activity evaluation. Pharmacist credit will be uploaded to CPE Monitor 4 weeks following receipt of a completed, qualified form.

Faculty Biography

Rami S. Komrokji, MD
Professor of Oncologic Sciences
University of South Florida
Clinical Director
Department of Hematologic Malignancies
Moffitt Cancer Center
Tampa, Florida

Dr. Rami Komrokji received his medical degree from Jordan University School of Medicine. He completed his internal medicine residency at Case Western Reserve University and his hematology/oncology fellowship at Strong Memorial Hospital, University of Rochester. He is a Professor of Oncologic Sciences at the University of South Florida College of Medicine, and Clinical Director in the Department of Malignant Hematology at Moffitt Cancer Center in Tampa, Florida.

Dr. Komrokji’s research focus is on phase I and II clinical trials in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). He is the lead clinical investigator for the MDS program at Moffitt Cancer Center where he has conducted several translational clinical trials and developed one of the largest MDS databases in the nation. In addition, he serves as the Moffitt Cancer Center principal investigator for the MDS Clinical Consortium, a collaboration between six of the largest MDS programs in the country to conduct clinical trials in MDS.

Accreditation

MediCom CME CREDIT
Accreditation Statement: MediCom Worldwide, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement: MediCom Worldwide, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACPE CPE CREDIT
MediCom Worldwide, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is acceptable for 0.75 contact hours of Continuing Education Credit. Universal Activity Number: 827-0000-17-141-H01-P. Knowledge-based CPE activity.

In order for CPE Monitor to authenticate credit, pharmacists/technicians must provide their e-Profile ID number from NABP and date of birth (in MMDD format) when claiming credit for a CPE program.

Disclosure

As an organization accredited by the Accreditation Council for Continuing Medical Education (ACCME), Accreditation Council for Pharmacy Education (ACPE) and California State Board of Registered Nursing, MediCom Worldwide, Inc. requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest. Accordingly, the following disclosures were made.

Faculty Disclosure

Dr. Rami Komrokji has received honoraria as a consultant from Celgene Corporation and Novartis AG; speakers’ bureau activities from Alexion and Novartis; as well as grant support related to research activities from Boehringer Ingelheim GmbH and Celgene.

Planning Committee Disclosures

The individuals listed below from MediCom Worldwide, Inc. reported the following for this activity: Joan Meyer, RN, MHA, Executive Director, has no relevant financial relationships.

Peer Reviewer Disclosure

In accordance with MediCom Worldwide, Inc. policy, all content is reviewed by external independent peer reviewers for balance, objectivity and commercial bias. The peer reviewers have no relevant financial relationships to disclose.

If you have any questions or concerns regarding this activity, please contact MediCom Worldwide, Inc. at 1-800-408-4242 or email us at lisa@medicaled.com.

Provided by MediCom Worldwide, Inc.
This activity is supported by an educational grant from Celgene Corporation.

©2017 MediCom Worldwide, Inc., 101 Washington St., Morrisville, PA 19067, 800-408-4242.
No portion of this material may be copied or duplicated without the expressed permission of MediCom Worldwide, Inc.

You need to be logged in to continue. Please Log In or Register using the box at the top right of this page.

Managing MDS would like to recognize and thank Celgene Corporation for their educational support of ManagingMDS.com

©2017 MediCom Worldwide, Inc. All rights reserved